Cohortias – New regulation make Argentina an excellent choice for clinical research.
The new regulation will accelerate the evaluation process from 160 business days to 70 days or less.
The new regulation will accelerate the evaluation process from 160 business days to 70 days or less.
For the first time in three years, the BIO International Convention will be back fully in person in San Diego, California.
In the trial, GLY-200 was found to be well-tolerated across all tested dose levels without any safety signals detected.
A Phase II trial will begin to support registration, once Myeloid establishes the recommended dose.
In the trial, vaccination with ABNCoV2 led to a substantial improvement in neutralizing antibodies against the Omicron variant.
The trial will evaluate the change in pain and function following subcutaneous injections of PPS versus placebo.
The open-label trial will assess the safety and efficacy of GT90001 plus Nivolumab in patients with advanced HCC.
Assessing the overall survival is the primary endpoint of the global trial.
The trial will assess the safety, tolerability, and pharmacokinetics of TST002 to treat individuals with osteoporosis.
The randomized, double-blind trial of Wakix will enroll nearly 200 IH patients in 60 to 80 trial sites in the US.